NCT06870383 Erector Spinae Block Versus Combined Pecto-intercostal and Recto-intercostal Fascial Plane Block in Cardiac Surgery
| NCT ID | NCT06870383 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Erector Spinae Plane Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2025-03-20 |
| Primary Completion | 2026-06-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2025-03-20 with a primary completion date of 2026-06-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to compare the analgesic effects of ultrasound-guided bilateral erector spinae plane block versus ultrasound-guided bilateral combined Pecto-intercostal fascial plane block and recto-intercostal fascial plane block in patients undergoing cardiac surgery.
Eligibility Criteria
Inclusion Criteria: * Age from 21 to 65 years. * Both sexes. * Scheduled for open heart surgery with cardiopulmonary bypass and midline sternotomy. Exclusion Criteria: * History of chronic pain or Long-term or recent use of opioids. * History of allergy to local anesthetic drugs. * Ejection fraction of left ventricle less than 30%. * History of psychiatric diseases or any neurological disorders. * Pre-existing major organ dysfunction as hepatic or renal failure.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06870383 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Erector Spinae Plane Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06870383 currently recruiting?
Yes, NCT06870383 is actively recruiting participants. Contact the research team at osamarehab@med.tanta.edu.eg for enrollment information.
Where is the NCT06870383 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT06870383 clinical trial?
NCT06870383 is sponsored by Tanta University. The trial plans to enroll 66 participants.